bioAffinity increases authorized common and preferred stock shares
The company amended its certificate of incorporation to raise the authorized total number of shares from 150,000,000 to 220,000,000. This regulatory change provides greater flexibility for potential future fund-raising activities in the capital markets.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed